Background: Current guidelines recommend androgen deprivation therapy only for men with very high-risk prostate cancer (PCa), but there is little evidence to support this stance. Objective: To investigate the association between radical local treatment and mortality in men with very high-risk PCa. Design, setting, and participants: Semiecologic study of men aged <80 yr within the Prostate Cancer data Base Sweden, diagnosed in 1998-2012 with very high-risk PCa (local clinical stage T4 and/or prostate-specific antigen [PSA] level 50-200 ng/ml, any N, and M0). Men with locally advanced PCa (local clinical stage T3 and PSA level <50 ng/ml, any N, and M0) were used as positive controls. Intervention: Proportion of men who received prostatectomy or full-dose radiotherapy in 640 experimental units defined by county, diagnostic period, and age at diagnosis. Outcome measurements and statistical analysis: PCa and all-cause mortality rate ratios (MRRs). Results and limitations: Both PCa and all-cause mortality were half as high in units in the highest tertile of exposure to radical local treatment compared with units in the lowest tertile (PCa MRR: 0.51; 95% confidence interval [CI], 0.28-0.95; and all-cause MRR: 0.56; 95% CI, 0.33-0.92). The results observed for locally advanced PCa for highest versus lowest tertile of exposure were in agreement with results from randomized trials (PCa MRR: 0.75; 95% CI, 0.60-0.94; and all-cause MRR: 0.85; 95% CI, 0.72-1.00). Although the semiecologic design minimized selection bias on an individual level, the effect of high therapeutic activity could not be separated from that of high diagnostic activity. Conclusions: The substantially lower mortality in units with the highest exposure to radical local treatment suggests that radical treatment decreases mortality even in men with very high-risk PCa for whom such treatment has been considered ineffective. Patient summary: Men with very high-risk prostate cancer diagnosed and treated in units with the highest exposure to surgery or radiotherapy had a substantially lower mortality. 
Introduction
There is no randomized controlled trial (RCT), to our knowledge, on the effect of radical local treatment in men with prostate cancer (PCa) in the ''gray zone'' between locally advanced and metastatic PCa. This risk category is often referred to as very high-risk PCa and is defined by local invasion into adjacent organs or very high levels of serum prostate-specific antigen (PSA) together with negative imaging findings for metastasis [1] [2] [3] [4] . The prognosis is poor, and radical local treatment has generally not been considered beneficial, as the local tumor often is too advanced to eradicate and there is a high likelihood of undetected micrometastases. Consequently, clinical guidelines recommend androgen deprivation therapy (ADT) only for men with very high-risk PCa [1, 2] . The only studies on radical local treatment for men with very high-risk PCa are small and retrospective [4] [5] [6] [7] [8] [9] [10] . These studies reported longer survival in men who underwent radical prostatectomy or full-dose radiotherapy than in men who received ADT only. The comparisons of treatment effects in observational studies are hampered by selection bias because most patients selected for radical local treatment have less adverse cancer characteristics than patients not receiving that treatment. Even if prognostic factors such as stage, grade, and PSA level are included in the analysis, there will be residual confounding in observational studies based on an analysis of treatment exposure on an individual level [11] .
The use of radical local treatment for very high-risk PCa has varied during the past 15 years between Swedish counties, which are geographically well-defined administrative units providing health care to the entire population in their catchment area. This provided a natural experiment, allowing us to investigate the association of radical local treatment with mortality from very high-risk PCa in a semiecologic study in which the effects of selection bias for exposure to treatment on an individual level were minimized and comprehensive individual-level data on cancer characteristics, treatment, and outcome could still be used.
There is consistent evidence from RCTs that radiotherapy combined with ADT improves survival of men with locally advanced PCa [12] [13] [14] [15] [16] [17] . To assess the validity of our results for very high-risk PCa, we also investigated the association between radical local treatment for locally advanced PCa and mortality with the same method as a positive control. The plausibility of our observations for the treatment effect on very high-risk PCa would be strengthened if we observed an association between radical local treatment of locally advanced PCa and mortality similar to the effect reported from the RCTs.
The aim of this study was to assess the association between radical local treatment and mortality in men with very high-risk PCa by relating exposure to radical local treatment on a population level in experimental units, defined by county, period, and age at diagnosis, to mortality from PCa and all causes using comprehensive individuallevel data on cancer characteristics, treatment, and outcome.
Methods
Prostate Cancer data Base Sweden (PCBaSe) 3.0 contains information obtained from the National Prostate Cancer Register (NPCR) of Sweden on cancer characteristics at diagnosis and on primary treatment [18] [19] [20] . PCBaSe also includes information on comorbidity, assessed by the Charlson Comorbidity Index (CCI) based on discharge diagnosis from the Patient Registry; education level, income, and marital status from the LISA database; and cause and date of death obtained from the Cause of Death Registry [21] [22] [23] [24] [25] . The study population within PCBaSe for this study included men aged <80 yr of age diagnosed in 1998-2012 with very high-risk PCa (T4 and/or PSA level 50-200 ng/ml, any N, and M0). To assess the validity of our method, we separately studied the association of local treatment and mortality in men with locally advanced PCa (local clinical stage T3 and PSA level <50 ng/ml, any N, and M0 [26, 27] . NPCR includes comprehensive information on radiotherapy since 2008; for men diagnosed before 2008, data were retrieved directly from oncological radiotherapy information systems and local databases in oncology departments on type of radiotherapy, treatment time, total dose, and fractions in RetroRad (Retrospective Registration of Radiotherapy, a nation wide audit) [28] . There are currently 20 counties in Sweden, and a large majority of health care including diagnostic and therapeutic activity for PCa is provided in the county of residence of the patient within a tax-financed equal access system. The study was approved by the Research Ethics Board at Umeå University. 
Results
There were 106 204 men aged <80 yr diagnosed with PCa in Sweden during the study period. Of these, 7500 men (7%) had very high-risk PCa and 10316 men (10%) had locally advanced PCa; for these men, there was a gradual increase in exposure to radical local treatment in most counties during the study period ( Fig. 1 ) and an increase in the proportion receiving radical treatment in all age groups ( Fig. 2 ). For instance, the proportion of men aged <65 yr with very high-risk PCa who received radical treatment increased from 21% in 1998-1999 to 41% in 2012, whereas the corresponding increase for locally advanced PCa was from 46% to 79%. There was a more than nine-fold difference between the counties with the highest and lowest proportions of radical treatment for very high-risk PCa (28% vs 3%, respectively) and more than two-fold difference of radical treatment for locally advanced PCa (53% vs 20%, respectively) during the full study period in all age groups combined. The use of radical treatment for very high-risk PCa and locally advanced PCa in each county according to calendar year is depicted in Supplementary Figs . 1 and 2. Clinical characteristics and cancer treatment for men with very high-risk and locally advanced PCa are presented in Table 1 . Men in the units in the highest tertile of exposure to radical local treatment compared with men in units with the lowest exposure were younger and had lower PSA levels, fewer comorbidities, and fewer missing data for complete Gleason classification (3% vs 26%, respectively). In an analysis ignoring the restriction to M0 in the very highrisk group, 92% vs 65% of men had undergone bone imaging in the units with highest and lowest exposure, respectively (Supplementary Table 1) .
Full-dose radiotherapy combined with ADT was the most common radical treatment; 8% of men with very high-risk PCa and 19% of men with locally advanced PCa received this treatment in the full study population. Details on the delivered radiotherapy are presented in Supplementary  Table 2 . Age was a strong determinant of receipt of radical local treatment ( Supplementary Fig. 3 ). Among men with very high-risk PCa, radical treatment was used in 32% of men aged <65 yr but only 2% of men aged 75-79 yr, and the corresponding proportions for men with locally advanced PCa were 66% and 6%, respectively.
3.1.
Mortality according to exposure to local treatment
Men with very high-risk PCa in the units in the highest tertile of exposure to radical local treatment had half the mortality of men in the lowest tertile (PCa MRR: 0.51; 95% CI, 0.28-0.95; and all-cause MRR: 0.56; 95% CI, 0.33-0.92) ( Table 2 and Fig. 3 Mortality in men with locally advanced PCa was also related to exposure to radical local treatment for the highest versus lowest tertile of exposure (PCa MRR: 0.75; 95% CI, 0.60-0.94; and all-cause MRR: 0.85; 95% CI, 0.72-1.00). The association between radical treatment and PCa mortality was observed in all age groups up to 75 yr (age <65 yr, MRR: 0.75; 95% CI, 0.55-1.03; age 65-69 yr, MRR: 0.73; 95% CI, 0.51-1.04; and age 70-74 yr, MRR: 0.36; 95% CI, 0.11-1.13). All comparisons between tertiles of exposure to radical treatment showed a statistically significant association with PCa and all-cause MRR (p < 0.05). Too few men aged >75 yr received radical treatment to allow a separate analysis in this age group (Supplementary Fig. 3 ).
Discussion
In men with very high-risk PCa, mortality from PCa and that from all causes were half as high in units with the highest exposure to radical local treatment as in the units with the lowest exposure in this semiecologic, nationwide, population-based study. This strong association suggests that radical local treatment decreases mortality even in men with very high-risk PCa for whom radical treatment has previously been considered ineffective. The semiecologic study design has several strengths [31, 32] . Exposure to treatment could be assessed on a population level, which minimized selection bias on an individual level, while at the same time comprehensive, high-quality individual-level data for cancer characteristics, comorbidity, cancer treatment, and cause of death could be used [18] [19] [20] 28] .
Residual confounding cannot be ruled out. Some counties consistently had a higher use of radical local 
treatment, and there may have been factors unrelated to treatment causing the lower mortality in these counties. Although the analysis was adjusted for county and year of diagnosis, there may have been interactions between these two factors that were left unaccounted for. High exposure to radical local treatment was linked to high exposure to staging investigations, including bone and lymph node imaging and complete Gleason classification. The design of the study allowed for an investigation of the association of a high diagnostic activity and a high therapeutic activity, assessed on a population level, with oncological outcome, assessed on an individual level, but the effects of diagnostic and therapeutic activity could not be separated. Most men aged <75 yr with very high-risk PCa die of their cancer [33, 34] . Despite this, radical local treatment of the primary tumor in addition to ADT has only been 
evaluated in some reports from small, single-institution case series [4] [5] [6] [7] [8] [9] [10] . These studies reported longer survival for men with very high-risk PCa who received full-dose radiotherapy or prostatectomy in addition to ADT, but selection bias cannot be ruled out as the only cause of these findings. In contrast, multimodal treatment of very advanced breast cancer is a well-researched area. There is strong evidence from RCTs that combinations of local and systemic treatment prolong survival, and combined treatment has long been the standard of care for women with very advanced breast cancer [35] . RCTs of ADT and radical prostatectomy or radiotherapy in men with very high-risk PCa (with or without confirmed limited metastatic spread) are ongoing [36] [37] [38] [39] [40] , but their results will not be available for many years. Results from large, well-designed studies based on registers with high-quality data can fill the current lack of evidence. This study included virtually all PCa cases in an entire nation, with comprehensive data from high-quality health care registries and demographic databases on cancer characteristics, cancer treatment, comorbidity, socioeconomic factors, and health care providers [18] [19] [20] . We also investigated the association between radical local treatment and mortality from locally advanced PCa (local clinical stage T3). The magnitude of the association between high exposure to radical local treatment and the decrease in mortality in men with locally advanced PCa was in accordance with the effect of local treatment reported from RCTs [12] [13] [14] [15] [16] [17] , implying that the methods we used yielded accurate risk estimates.
In this study, lymph node metastasis detected at surgery (pN1) was not used as an inclusion criterion because men 
with pN1 detected at prostatectomy for clinically localized PCa have a better prognosis than men with stage T4 cancer or a PSA level of 50-200 ng/ml [8, 33] . Had pN1 disease been included in the very high-risk PCa group, more men in this subgroup with favorable prognosis would have been included in units with high exposure to radical local treatment, and this would have introduced selection bias.
Conclusions
In this semiecologic, nationwide, population-based study, mortality among men with very high-risk PCa (defined as local stage T4, PSA level 50-200 ng/ml, and M0) in experimental units with the highest exposure to radical local treatment was half that from PCa and all causes in units with the lowest exposure. This suggests that radical local treatment decreases mortality in men with very highrisk PCa for whom radical treatment has previously been considered ineffective. RCTs are needed to conclusively evaluate the effect of radical local treatment in men with very high-risk PCa. Drafting of the manuscript: Stattin, Thomsen.
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